{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T23:34:57Z","timestamp":1788305697515,"version":"build-2803163510"},"reference-count":108,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T00:00:00Z","timestamp":1741651200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T00:00:00Z","timestamp":1741651200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biochem Genet"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s10528-025-11078-3","type":"journal-article","created":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T12:00:08Z","timestamp":1741694408000},"page":"1-26","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Harnessing State-of-the-Art Gene Therapy to Transform Oral Cancer Treatment"],"prefix":"10.1007","volume":"64","author":[{"given":"Wei","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaowen","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-8653-166X","authenticated-orcid":false,"given":"Hongyan","family":"Chai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,11]]},"reference":[{"issue":"4","key":"11078_CR1","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.ejps.2009.09.010","volume":"38","author":"M Ag\u00fceros","year":"2009","unstructured":"Ag\u00fceros M, Ruiz-Gat\u00f3n L, Vauthier C, Bouchemal K, Espuelas S, Ponchel G et al (2009) Combined hydroxypropyl-\u03b2-cyclodextrin and poly (anhydride) nanoparticles improve the oral permeability of paclitaxel. Eur J Pharm Sci 38(4):405\u2013413","journal-title":"Eur J Pharm Sci"},{"key":"11078_CR2","doi-asserted-by":"crossref","unstructured":"Alimi N, Hamidi Madani Z, Saranjam R, Shoarishoar SS, Massoudifar A, Haghighi Z et al. (2024) Investigating body dysmorphic disorder in pregnant mothers requesting cesarean section. J Obst Gynecol Cancer Res.","DOI":"10.24200\/jogcr.10.11.825"},{"key":"11078_CR3","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1146\/annurev-med-012017-043332","volume":"70","author":"XM Anguela","year":"2019","unstructured":"Anguela XM, High KA (2019) Entering the modern era of gene therapy. Annu Rev Med 70:273\u2013288","journal-title":"Annu Rev Med"},{"issue":"4","key":"11078_CR4","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1016\/S0006-291X(02)02013-2","volume":"296","author":"J-R Bertrand","year":"2002","unstructured":"Bertrand J-R, Pottier M, Vekris A, Opolon P, Maksimenko A, Malvy C (2002) Comparison of antisense oligonucleotides and siRNAs in cell culture and in vivo. Biochem Biophys Res Commun 296(4):1000\u20131004","journal-title":"Biochem Biophys Res Commun"},{"issue":"8","key":"11078_CR5","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1242\/dmm.030148","volume":"10","author":"M Bowerman","year":"2017","unstructured":"Bowerman M, Becker CG, Y\u00e1\u00f1ez-Mu\u00f1oz RJ, Ning K, Wood MJ, Gillingwater TH et al (2017) Therapeutic strategies for spinal muscular atrophy: SMN and beyond. Dis Model Mech 10(8):943\u2013954","journal-title":"Dis Model Mech"},{"issue":"10","key":"11078_CR6","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1038\/sj.gt.3301003","volume":"6","author":"A Chahlavi","year":"1999","unstructured":"Chahlavi A, Rabkin S, Todo T, Sundaresan P, Martuza R (1999) Effect of prior exposure to herpes simplex virus 1 on viral vector-mediated tumor therapy in immunocompetent mice. Gene Ther 6(10):1751\u20131758","journal-title":"Gene Ther"},{"issue":"42","key":"11078_CR7","doi-asserted-by":"publisher","first-page":"8293","DOI":"10.1039\/C5TB01393C","volume":"3","author":"C-W Chen","year":"2015","unstructured":"Chen C-W, Lee P-H, Chan Y-C, Hsiao M, Chen C-H, Wu PC et al (2015) Plasmon-induced hyperthermia: hybrid upconversion NaYF 4: Yb\/Er and gold nanomaterials for oral cancer photothermal therapy. J Mater Chem B 3(42):8293\u20138302","journal-title":"J Mater Chem B"},{"issue":"1","key":"11078_CR8","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s10555-017-9717-6","volume":"37","author":"X Chen","year":"2018","unstructured":"Chen X, Mangala LS, Rodriguez-Aguayo C, Kong X, Lopez-Berestein G, Sood AK (2018) RNA interference-based therapy and its delivery systems. Cancer Metastasis Rev 37(1):107\u2013124","journal-title":"Cancer Metastasis Rev"},{"issue":"1","key":"11078_CR9","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.oraloncology.2013.09.011","volume":"50","author":"SK Choudhari","year":"2014","unstructured":"Choudhari SK, Chaudhary M, Gadbail AR, Sharma A, Tekade S (2014) Oxidative and antioxidative mechanisms in oral cancer and precancer: a review. Oral Oncol 50(1):10\u201318","journal-title":"Oral Oncol"},{"issue":"8","key":"11078_CR10","first-page":"777","volume":"132","author":"VA Chow","year":"2018","unstructured":"Chow VA, Shadman M, Gopal AK (2018) Translating anti-CD19 CAR T-cell therapy into clinical practice for relapsed\/refractory diffuse large B-cell lymphoma. Blood, J Am Soc Hematol 132(8):777\u2013781","journal-title":"Blood, J Am Soc Hematol"},{"issue":"11","key":"11078_CR11","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1089\/104303403322124783","volume":"14","author":"P Cirone","year":"2003","unstructured":"Cirone P, Bourgeois JM, Chang PL (2003) Antiangiogenic cancer therapy with microencapsulated cells. Hum Gene Ther 14(11):1065\u20131077","journal-title":"Hum Gene Ther"},{"issue":"6","key":"11078_CR12","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.3892\/ijo.2014.2355","volume":"44","author":"T Dalianis","year":"2014","unstructured":"Dalianis T (2014) Human papillomavirus and oropharyngeal cancer, the epidemics, and significance of additional clinical biomarkers for prediction of response to therapy. Int J Oncol 44(6):1799\u20131805","journal-title":"Int J Oncol"},{"issue":"1","key":"11078_CR13","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/sj.cgt.7700529","volume":"10","author":"H Dehari","year":"2003","unstructured":"Dehari H, Ito Y, Nakamura T, Kobune M, Sasaki K, Yonekura N et al (2003) Enhanced antitumor effect of RGD fiber-modified adenovirus for gene therapy of oral cancer. Cancer Gene Ther 10(1):75\u201385","journal-title":"Cancer Gene Ther"},{"issue":"3","key":"11078_CR14","doi-asserted-by":"publisher","first-page":"274","DOI":"10.2174\/1573409919666230612125440","volume":"20","author":"I Farhani","year":"2024","unstructured":"Farhani I, Yamchi A, Madanchi H, Khazaei V, Behrouzikhah M, Abbasi H et al (2024) Designing a multi-epitope vaccine against the SARS-CoV-2 variant based on an immunoinformatics approach. Curr Comput Aided Drug des 20(3):274\u2013290","journal-title":"Curr Comput Aided Drug des"},{"issue":"10","key":"11078_CR15","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1111\/cas.13027","volume":"107","author":"H Fukuhara","year":"2016","unstructured":"Fukuhara H, Ino Y, Todo T (2016) Oncolytic virus therapy: a new era of cancer treatment at dawn. Cancer Sci 107(10):1373\u20131379","journal-title":"Cancer Sci"},{"issue":"3","key":"11078_CR16","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/S1368-8375(00)00093-2","volume":"37","author":"T Fukui","year":"2001","unstructured":"Fukui T, Hayashi Y, Kagami H, Yamamoto N, Fukuhara H, Tohnai I et al (2001) Suicide gene therapy for human oral squamous cell carcinoma cell lines with adeno-associated virus vector. Oral Oncol 37(3):211\u2013215","journal-title":"Oral Oncol"},{"issue":"2","key":"11078_CR17","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1002\/hed.10004","volume":"24","author":"GF Funk","year":"2002","unstructured":"Funk GF, Karnell LH, Robinson RA, Zhen WK, Trask DK, Hoffman HT (2002) Presentation, treatment, and outcome of oral cavity cancer: a national cancer data base report. Head Neck 24(2):165\u2013180","journal-title":"Head Neck"},{"issue":"5","key":"11078_CR18","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1038\/sj.gt.3302436","volume":"12","author":"E Galanis","year":"2005","unstructured":"Galanis E, Okuno S, Nascimento A, Lewis B, Lee R, Oliveira A et al (2005) Phase I-II trial of ONYX-015 in combination with MAP chemotherapy in patients with advanced sarcomas. Gene Ther 12(5):437\u2013445","journal-title":"Gene Ther"},{"issue":"1","key":"11078_CR19","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1002\/ijc.23033","volume":"122","author":"S Gandini","year":"2008","unstructured":"Gandini S, Botteri E, Iodice S, Boniol M, Lowenfels AB, Maisonneuve P et al (2008) Tobacco smoking and cancer: a meta-analysis. Int J Cancer 122(1):155\u2013164","journal-title":"Int J Cancer"},{"issue":"4","key":"11078_CR20","first-page":"110","volume":"11","author":"R Gardl\u00edk","year":"2005","unstructured":"Gardl\u00edk R, P\u00e1lffy R, Hodosy J, Luk\u00e1cs J, Turna J, Celec P (2005) Vectors and delivery systems in gene therapy. Med Sci Monit 11(4):110\u2013121","journal-title":"Med Sci Monit"},{"key":"11078_CR21","doi-asserted-by":"publisher","first-page":"9383","DOI":"10.1007\/s11033-012-1802-x","volume":"39","author":"T Ghosh","year":"2012","unstructured":"Ghosh T, Gupta S, Bajpai P, Agarwal D, Agarwal M, Gupta O et al (2012) Association of CYP1A1, GSTM1, and GSTT1 gene polymorphism with risk of oral submucous fibrosis in a section of North Indian population. Mol Biol Rep 39:9383\u20139389","journal-title":"Mol Biol Rep"},{"issue":"5","key":"11078_CR22","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1097\/00005537-200005000-00002","volume":"110","author":"LL Gleich","year":"2000","unstructured":"Gleich LL (2000) Gene therapy for head and neck cancer. Laryngoscope 110(5):708\u2013726","journal-title":"Laryngoscope"},{"issue":"7","key":"11078_CR23","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/sj.cgt.7700602","volume":"10","author":"MM Gottesman","year":"2003","unstructured":"Gottesman MM (2003) Cancer gene therapy: an awkward adolescence. Cancer Gene Ther 10(7):501\u2013508","journal-title":"Cancer Gene Ther"},{"issue":"1","key":"11078_CR24","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/nrc706","volume":"2","author":"MM Gottesman","year":"2002","unstructured":"Gottesman MM, Fojo T, Bates SE (2002) Multidrug resistance in cancer: role of ATP\u2013dependent transporters. Nat Rev Cancer 2(1):48\u201358","journal-title":"Nat Rev Cancer"},{"issue":"11","key":"11078_CR25","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1056\/NEJMra0707975","volume":"359","author":"RI Haddad","year":"2008","unstructured":"Haddad RI, Shin DM (2008) Recent advances in head and neck cancer. N Engl J Med 359(11):1143\u20131154","journal-title":"N Engl J Med"},{"issue":"19","key":"11078_CR26","doi-asserted-by":"publisher","first-page":"4514","DOI":"10.1002\/cncr.24525","volume":"115","author":"R Haddad","year":"2009","unstructured":"Haddad R, Sonis S, Posner M, Wirth L, Costello R, Braschayko P et al (2009) Randomized phase 2 study of concomitant chemoradiotherapy using weekly carboplatin\/paclitaxel with or without daily subcutaneous amifostine in patients with locally advanced head and neck cancer. Cancer: Interdiscip Int J Am Cancer Soc 115(19):4514\u20134523","journal-title":"Cancer: Interdiscip Int J Am Cancer Soc"},{"issue":"7","key":"11078_CR27","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/j.oraloncology.2004.01.002","volume":"40","author":"K Harada","year":"2004","unstructured":"Harada K, Kawaguchi S-I, Onoue T, Yoshida H, Sato M (2004) Characteristics of antitumor activity of mutant type p27Kip1 gene in an oral cancer cell line. Oral Oncol 40(7):679\u2013687","journal-title":"Oral Oncol"},{"issue":"2","key":"11078_CR28","doi-asserted-by":"publisher","first-page":"65","DOI":"10.3390\/genes8020065","volume":"8","author":"CL Hardee","year":"2017","unstructured":"Hardee CL, Ar\u00e9valo-Soliz LM, Hornstein BD, Zechiedrich L (2017) Advances in non-viral DNA vectors for gene therapy. Genes 8(2):65","journal-title":"Genes"},{"issue":"1","key":"11078_CR29","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/S1470-2045(01)00618-0","volume":"3","author":"LK Hawkins","year":"2002","unstructured":"Hawkins LK, Lemoine NR, Kirn D (2002) Oncolytic biotherapy: a novel therapeutic platform. Lancet Oncol 3(1):17\u201326","journal-title":"Lancet Oncol"},{"issue":"7","key":"11078_CR30","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1172\/JCI9762","volume":"105","author":"C Heise","year":"2000","unstructured":"Heise C, Kirn DH (2000) Replication-selective adenoviruses as oncolytic agents. J Clin Investig 105(7):847\u2013851","journal-title":"J Clin Investig"},{"issue":"6","key":"11078_CR31","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1093\/carcin\/bgy053","volume":"39","author":"J-R Hsiao","year":"2018","unstructured":"Hsiao J-R, Chang C-C, Lee W-T, Huang C-C, Ou C-Y, Tsai S-T et al (2018) The interplay between oral microbiome, lifestyle factors and genetic polymorphisms in the risk of oral squamous cell carcinoma. Carcinogenesis 39(6):778\u2013787","journal-title":"Carcinogenesis"},{"key":"11078_CR32","unstructured":"Humans IWGotEoCRt, Cancer IAfRo (2007) Smokeless tobacco and some tobacco-specific N-nitrosamines. World Health Organization."},{"issue":"11","key":"11078_CR33","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1089\/104303403322124765","volume":"14","author":"M Imboden","year":"2003","unstructured":"Imboden M, Shi F, Pugh TD, Freud AG, Thom NJ, Hank JA et al (2003) Safety of interleukin-12 gene therapy against cancer: a murine biodistribution and toxicity study. Hum Gene Ther 14(11):1037\u20131048","journal-title":"Hum Gene Ther"},{"issue":"2","key":"11078_CR34","doi-asserted-by":"publisher","first-page":"83","DOI":"10.4103\/0975-8844.124249","volume":"5","author":"S Indu","year":"2013","unstructured":"Indu S, Ramesh V, Oza N, Prashad KV (2013) Gene therapy: an overview. J Orofac Sci 5(2):83\u201387","journal-title":"J Orofac Sci"},{"issue":"2","key":"11078_CR35","first-page":"315","volume":"30","author":"M Jafarlou","year":"2016","unstructured":"Jafarlou M, Baradaran B, Saedi T, Jafarlou V, Shanehbandi D, Maralani M et al (2016) An overview of the history, applications, advantages, disadvantages and prospects of gene therapy. J Biol Regul Homeost Agents 30(2):315\u2013321","journal-title":"J Biol Regul Homeost Agents"},{"issue":"1","key":"11078_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2022.113442","volume":"423","author":"MJ Kamali","year":"2023","unstructured":"Kamali MJ, Salehi M, Fatemi S, Moradi F, Khoshghiafeh A, Ahmadifard M (2023) Locked nucleic acid (LNA): a modern approach to cancer diagnosis and treatment. Exp Cell Res 423(1):113442","journal-title":"Exp Cell Res"},{"issue":"2","key":"11078_CR37","doi-asserted-by":"publisher","DOI":"10.1002\/rmv.2530","volume":"34","author":"MJ Kamali","year":"2024","unstructured":"Kamali MJ, Salehi M, Mostafavi M, Morovatshoar R, Akbari M, Latifi N et al (2024) Hijacking and rewiring of host CircRNA\/miRNA\/mRNA competitive endogenous RNA (ceRNA) regulatory networks by oncoviruses during development of viral cancers. Rev Med Virol 34(2):e2530","journal-title":"Rev Med Virol"},{"key":"11078_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiomed.2025.109885","volume":"188","author":"MJ Kamali","year":"2025","unstructured":"Kamali MJ, Salehi M, Fath MK (2025) Advancing personalized immunotherapy for melanoma: integrating immunoinformatics in multi-epitope vaccine development, neoantigen identification via NGS, and immune simulation evaluation. Comput Biol Med 188:109885","journal-title":"Comput Biol Med"},{"issue":"1","key":"11078_CR39","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrclinonc.2014.192","volume":"12","author":"H Kang","year":"2015","unstructured":"Kang H, Kiess A, Chung CH (2015) Emerging biomarkers in head and neck cancer in the era of genomics. Nat Rev Clin Oncol 12(1):11\u201326","journal-title":"Nat Rev Clin Oncol"},{"issue":"4","key":"11078_CR40","doi-asserted-by":"publisher","first-page":"479","DOI":"10.31557\/apjcb.2024.9.4.479-486","volume":"9","author":"N Khaje","year":"2024","unstructured":"Khaje N, Salehan F, Shakiba D, Shabestari AM, Shoarishoar SS (2024) In vitro assessment of paclitaxel-loaded niosome nanoparticles and their cytotoxic effects on the ovarian cancer cell line A2780CP. Asian Pacific J Cancer Biol 9(4):479\u2013486","journal-title":"Asian Pacific J Cancer Biol"},{"key":"11078_CR41","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.copbio.2018.11.016","volume":"60","author":"DB Kohn","year":"2019","unstructured":"Kohn DB (2019) Gene therapy for blood diseases. Curr Opin Biotechnol 60:39\u201345","journal-title":"Curr Opin Biotechnol"},{"issue":"1","key":"11078_CR42","doi-asserted-by":"publisher","first-page":"66","DOI":"10.7150\/jca.5112","volume":"4","author":"S Koontongkaew","year":"2013","unstructured":"Koontongkaew S (2013) The tumor microenvironment contribution to development, growth, invasion and metastasis of head and neck squamous cell carcinomas. J Cancer 4(1):66","journal-title":"J Cancer"},{"issue":"6","key":"11078_CR43","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1634\/theoncologist.7-6-516","volume":"7","author":"C Kruijtzer","year":"2002","unstructured":"Kruijtzer C, Beijnen J, Schellens J (2002) Improvement of oral drug treatment by temporary inhibition of drug transporters and\/or cytochrome P450 in the gastrointestinal tract and liver: an overview. Oncologist 7(6):516\u2013530","journal-title":"Oncologist"},{"issue":"6","key":"11078_CR44","first-page":"1261","volume":"7","author":"MS Kumar","year":"2013","unstructured":"Kumar MS, Masthan K, Babu NA, Dash KC (2013) Gene therapy in oral cancer: a review. J Clin Diagn Res: JCDR 7(6):1261","journal-title":"J Clin Diagn Res: JCDR"},{"key":"11078_CR45","doi-asserted-by":"publisher","first-page":"16034","DOI":"10.1038\/mtm.2016.34","volume":"3","author":"SR Kumar","year":"2016","unstructured":"Kumar SR, Markusic DM, Biswas M, High KA, Herzog RW (2016) Clinical development of gene therapy: results and lessons from recent successes. Mol Ther-Methods Clin Dev 3:16034","journal-title":"Mol Ther-Methods Clin Dev"},{"issue":"12","key":"11078_CR46","doi-asserted-by":"publisher","first-page":"3353","DOI":"10.1158\/1055-9965.EPI-09-0910","volume":"18","author":"Y-CA Lee","year":"2009","unstructured":"Lee Y-CA, Marron M, Benhamou S, Bouchardy C, Ahrens W, Pohlabeln H et al (2009) Active and involuntary tobacco smoking and upper aerodigestive tract cancer risks in a multicenter case-control study. Cancer Epidemiol, Biomark Prev 18(12):3353\u20133361","journal-title":"Cancer Epidemiol, Biomark Prev"},{"issue":"12","key":"11078_CR47","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1016\/j.oraloncology.2008.03.004","volume":"44","author":"X Liang","year":"2008","unstructured":"Liang X, Yang X, Tang Y, Zhou H, Liu X, Xiao L et al (2008) RNAi-mediated downregulation of urokinase plasminogen activator receptor inhibits proliferation, adhesion, migration and invasion in oral cancer cells. Oral Oncol 44(12):1172\u20131180","journal-title":"Oral Oncol"},{"issue":"14","key":"11078_CR48","first-page":"3662","volume":"54","author":"T-J Liu","year":"1994","unstructured":"Liu T-J, Zhang W-W, Taylor DL, Roth JA, Goepfert H, Clayman GL (1994) Growth suppression of human head and neck cancer cells by the introduction of a wild-type p53 gene via a recombinant adenovirus. Can Res 54(14):3662\u20133667","journal-title":"Can Res"},{"issue":"2","key":"11078_CR49","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1158\/0008-5472.CAN-20-0554","volume":"81","author":"J Liu","year":"2021","unstructured":"Liu J, Jiang X, Zou A, Mai Z, Huang Z, Sun L et al (2021) circIGHG-induced epithelial-to-mesenchymal transition promotes oral squamous cell carcinoma progression via miR-142-5p\/IGF2BP3 signaling. Can Res 81(2):344\u2013355","journal-title":"Can Res"},{"issue":"2","key":"11078_CR50","first-page":"108","volume":"7","author":"M Lopez-Martinez","year":"2002","unstructured":"Lopez-Martinez M, Anzola M, Cuevas N, Aguirre J, De-Pancorbo M (2002) Clinical applications of the diagnosis of p53 alterations in squamous cell carcinoma of the head and neck. Med Oral: Organo Oficial De La Sociedad Espanola De Medicina Oral y De La Academia Iberoamericana De Patologia y Medicina Bucal 7(2):108\u2013120","journal-title":"Med Oral: Organo Oficial De La Sociedad Espanola De Medicina Oral y De La Academia Iberoamericana De Patologia y Medicina Bucal"},{"issue":"3","key":"11078_CR51","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1039\/C6BM00833J","volume":"5","author":"C Ma","year":"2017","unstructured":"Ma C, Shi L, Huang Y, Shen L, Peng H, Zhu X et al (2017) Nanoparticle delivery of Wnt-1 siRNA enhances photodynamic therapy by inhibiting epithelial\u2013mesenchymal transition for oral cancer. Biomater Sci 5(3):494\u2013501","journal-title":"Biomater Sci"},{"issue":"7","key":"11078_CR52","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1007\/s00018-022-04369-0","volume":"79","author":"SN Marikar","year":"2022","unstructured":"Marikar SN, El-Osta A, Johnston A, Such G, Al-Hasani K (2022) Microencapsulation-based cell therapies. Cell Mol Life Sci 79(7):351","journal-title":"Cell Mol Life Sci"},{"issue":"1","key":"11078_CR53","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1093\/ije\/dyp291","volume":"39","author":"M Marron","year":"2010","unstructured":"Marron M, Boffetta P, Zhang Z-F, Zaridze D, W\u00fcnsch-Filho V, Winn DM et al (2010) Cessation of alcohol drinking, tobacco smoking and the reversal of head and neck cancer risk. Int J Epidemiol 39(1):182\u2013196","journal-title":"Int J Epidemiol"},{"issue":"11","key":"11078_CR54","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1056\/NEJMoa1805689","volume":"379","author":"MS Maurer","year":"2018","unstructured":"Maurer MS, Schwartz JH, Gundapaneni B, Elliott PM, Merlini G, Waddington-Cruz M et al (2018) Tafamidis treatment for patients with transthyretin amyloid cardiomyopathy. N Engl J Med 379(11):1007\u20131016","journal-title":"N Engl J Med"},{"key":"11078_CR55","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1007\/s12013-014-9849-z","volume":"69","author":"L Miao","year":"2014","unstructured":"Miao L, Liu C, Ge J, Yang W, Liu J, Sun W et al (2014) Antitumor effect of TRAIL on oral squamous cell carcinoma using magnetic nanoparticle-mediated gene expression. Cell Biochem Biophys 69:663\u2013672","journal-title":"Cell Biochem Biophys"},{"issue":"2","key":"11078_CR56","doi-asserted-by":"publisher","first-page":"390","DOI":"10.4103\/jomfp.jomfp_46_23","volume":"27","author":"B Modak","year":"2023","unstructured":"Modak B, Solomon MC, Karmakar S, Polley S (2023) Gene therapy as a treatment of oral cancer: an insight. J Oral Maxillofac Pathol 27(2):390\u2013395","journal-title":"J Oral Maxillofac Pathol"},{"key":"11078_CR57","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.taap.2017.07.008","volume":"330","author":"A Nayak","year":"2017","unstructured":"Nayak A, Siddharth S, Das S, Nayak D, Sethy C, Kundu CN (2017) Nanoquinacrine caused apoptosis in oral cancer stem cells by disrupting the interaction between GLI1 and \u03b2 catenin through activation of GSK3\u03b2. Toxicol Appl Pharmacol 330:53\u201364","journal-title":"Toxicol Appl Pharmacol"},{"key":"11078_CR58","doi-asserted-by":"publisher","first-page":"27","DOI":"10.4103\/2277-9175.98152","volume":"1","author":"N Nayerossadat","year":"2012","unstructured":"Nayerossadat N, Maedeh T, Ali PA (2012) Viral and nonviral delivery systems for gene delivery. Adv Biomed Res 1:27","journal-title":"Adv Biomed Res"},{"issue":"22","key":"11078_CR59","first-page":"6359","volume":"60","author":"J Nemunaitis","year":"2000","unstructured":"Nemunaitis J, Ganly I, Khuri F, Arseneau J, Kuhn J, McCarty T et al (2000) Selective replication and oncolysis in p53 mutant tumors with ONYX-015, an E1B\u201355kD gene-deleted adenovirus, in patients with advanced head and neck cancer: a phase II trial. Can Res 60(22):6359\u20136366","journal-title":"Can Res"},{"issue":"5","key":"11078_CR60","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/sj.cgt.7700585","volume":"10","author":"J Nemunaitis","year":"2003","unstructured":"Nemunaitis J, Cunningham C, Tong AW, Post L, Netto G, Paulson AS et al (2003) Pilot trial of intravenous infusion of a replication-selective adenovirus (ONYX-015) in combination with chemotherapy or IL-2 treatment in refractory cancer patients. Cancer Gene Ther 10(5):341\u2013352","journal-title":"Cancer Gene Ther"},{"issue":"11","key":"11078_CR61","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1016\/j.bbamem.2006.08.021","volume":"1758","author":"SS Neves","year":"2006","unstructured":"Neves SS, Sarmento-Ribeiro AB, Sim\u00f5es SP, de Lima MCP (2006) Transfection of oral cancer cells mediated by transferrin-associated lipoplexes: mechanisms of cell death induced by herpes simplex virus thymidine kinase\/ganciclovir therapy. Biochim Biophys Acta Biomembr 1758(11):1703\u20131712","journal-title":"Biochim Biophys Acta Biomembr"},{"key":"11078_CR62","volume-title":"Oral and maxillofacial pathology","author":"B Neville","year":"2009","unstructured":"Neville B, Damm D, Allen C, Bouquot J (2009) Oral and maxillofacial pathology. Saunders Elsevier, St. Louis"},{"issue":"12","key":"11078_CR63","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1038\/nm1202-794","volume":"8","author":"AG Niethammer","year":"2002","unstructured":"Niethammer AG, Xiang R, Becker JC, Wodrich H, Pertl U, Karsten G et al (2002) A DNA vaccine against VEGF receptor 2 prevents effective angiogenesis and inhibits tumor growth. Nat Med 8(12):1369\u20131375","journal-title":"Nat Med"},{"issue":"8","key":"11078_CR64","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/S1368-8375(02)00039-8","volume":"38","author":"H Okamura","year":"2002","unstructured":"Okamura H, Morimoto H, Fujita M, Nasu F, Sasaki E, Haneji T (2002) Suppression of Egr-1 expression in human oral squamous carcinoma cells by okadaic acid. Oral Oncol 38(8):779\u2013784","journal-title":"Oral Oncol"},{"issue":"9","key":"11078_CR65","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1089\/hum.2005.16.1016","volume":"16","author":"Z Peng","year":"2005","unstructured":"Peng Z (2005) Current status of gendicine in China: recombinant human Ad-p53 agent for treatment of cancers. Hum Gene Ther 16(9):1016\u20131027","journal-title":"Hum Gene Ther"},{"issue":"2","key":"11078_CR66","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/s41419-020-2273-y","volume":"11","author":"Q-S Peng","year":"2020","unstructured":"Peng Q-S, Cheng Y-N, Zhang W-B, Fan H, Mao Q-H, Xu P (2020) circRNA_0000140 suppresses oral squamous cell carcinoma growth and metastasis by targeting miR-31 to inhibit Hippo signaling pathway. Cell Death Dis 11(2):112","journal-title":"Cell Death Dis"},{"issue":"1","key":"11078_CR67","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/S1074-7613(02)00266-2","volume":"16","author":"OD Perez","year":"2002","unstructured":"Perez OD, Kinoshita S, Hitoshi Y, Payan DG, Kitamura T, Nolan GP et al (2002) Activation of the PKB\/AKT pathway by ICAM-2. Immunity 16(1):51\u201365","journal-title":"Immunity"},{"issue":"10","key":"11078_CR68","first-page":"5389","volume":"37","author":"LP Pisani","year":"2017","unstructured":"Pisani LP, Estadella D, Ribeiro DA (2017) The role of toll like receptors (TLRs) in oral carcinogenesis. Anticancer Res 37(10):5389\u20135394","journal-title":"Anticancer Res"},{"key":"11078_CR69","doi-asserted-by":"publisher","DOI":"10.1016\/j.oor.2024.100678","volume":"12","author":"S Ramachandran","year":"2024","unstructured":"Ramachandran S (2024) Oral cancer: Recent breakthroughs in pathology and therapeutic approaches. Oral Oncol Rep 12:100678","journal-title":"Oral Oncol Rep"},{"issue":"4","key":"11078_CR70","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.oraloncology.2005.08.010","volume":"42","author":"S Ramachandran","year":"2006","unstructured":"Ramachandran S, Ramadas K, Hariharan R, Kumar RR, Pillai MR (2006) Single nucleotide polymorphisms of DNA repair genes XRCC1 and XPD and its molecular mapping in Indian oral cancer. Oral Oncol 42(4):350\u2013362","journal-title":"Oral Oncol"},{"key":"11078_CR71","doi-asserted-by":"publisher","first-page":"13","DOI":"10.2174\/1874467210801010013","volume":"1","author":"J R\u00e4ty","year":"2008","unstructured":"R\u00e4ty J, Pikkarainen J, Wirth T, Yl\u00e4-Herttuala S (2008) Gene therapy: the first approved gene-based medicines, molecular mechanisms and clinical indications. Curr Mol Pharmacol 1:13\u201323","journal-title":"Curr Mol Pharmacol"},{"issue":"5","key":"11078_CR72","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.surge.2011.01.010","volume":"9","author":"J Reidy","year":"2011","unstructured":"Reidy J, McHugh E, Stassen L (2011) A review of the relationship between alcohol and oral cancer. Surgeon 9(5):278\u2013283","journal-title":"Surgeon"},{"issue":"24","key":"11078_CR73","doi-asserted-by":"publisher","first-page":"4546","DOI":"10.1200\/JCO.2003.03.544","volume":"21","author":"CM Rudin","year":"2003","unstructured":"Rudin CM, Cohen EE, Papadimitrakopoulou VA, Silverman S Jr, Recant W, El-Naggar AK et al (2003) An attenuated adenovirus, ONYX-015, as mouthwash therapy for premalignant oral dysplasia. J Clin Oncol: off J Am Soc Clin Oncol 21(24):4546","journal-title":"J Clin Oncol: off J Am Soc Clin Oncol"},{"issue":"1","key":"11078_CR74","first-page":"20","volume":"7","author":"DW Sabea","year":"2023","unstructured":"Sabea DW, Al-Mahmood S, Salih HM (2023) A novel approach in diagnosis and treatment of oral cancer. Int J Surg 7(1):20\u201328","journal-title":"Int J Surg"},{"issue":"6","key":"11078_CR75","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1007\/s12032-024-02339-z","volume":"41","author":"F Saeedi","year":"2024","unstructured":"Saeedi F, Salehi M, Kamali MJ, Mir MA, Kazemi S, Shirafkan F et al (2024) Evaluation of the cytotoxic activities of the essential oil from Pistacia atlantica Desf. oleoresin on human gastric cancer cell lines. Med Oncol 41(6):148","journal-title":"Med Oncol"},{"key":"11078_CR76","doi-asserted-by":"publisher","first-page":"101901","DOI":"10.1016\/j.genrep.2024.101901","volume":"35","author":"M Salehi","year":"2024","unstructured":"Salehi M, Kamali MJ, Ashuori Z, Ghadimi F, Shafiee M, Babaei S et al (2024a) Functional significance of tRNA-derived fragments in sustained proliferation of tumor cells. Gene Rep 35:101901","journal-title":"Gene Rep"},{"key":"11078_CR77","doi-asserted-by":"publisher","DOI":"10.1016\/j.abb.2024.109930","volume":"753","author":"M Salehi","year":"2024","unstructured":"Salehi M, Kamali MJ, Rajabzadeh A, Minoo S, Mosharafi H, Saeedi F et al (2024b) tRNA-derived fragments: key determinants of cancer metastasis with emerging therapeutic and diagnostic potentials. Arch Biochem Biophys 753:109930","journal-title":"Arch Biochem Biophys"},{"key":"11078_CR78","volume":"37","author":"M Salehi","year":"2024","unstructured":"Salehi M, Kamali MJ, Arab D, Safaeian N, Ashuori Z, Maddahi M et al (2024c) Exosomal microRNAs in regulation of tumor cells resistance to apoptosis. Biochem Biophys Rep 37:101644","journal-title":"Biochem Biophys Rep"},{"issue":"1","key":"11078_CR79","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/nbt1176","volume":"24","author":"S Samakoglu","year":"2006","unstructured":"Samakoglu S, Lisowski L, Budak-Alpdogan T, Usachenko Y, Acuto S, Di Marzo R et al (2006) A genetic strategy to treat sickle cell anemia by coregulating globin transgene expression and RNA interference. Nat Biotechnol 24(1):89\u201394","journal-title":"Nat Biotechnol"},{"issue":"2A","key":"11078_CR80","first-page":"501","volume":"24","author":"KJ Scanlon","year":"2004","unstructured":"Scanlon KJ (2004) Cancer gene therapy: challenges and opportunities. Anticancer Res 24(2A):501\u2013504","journal-title":"Anticancer Res"},{"key":"11078_CR81","doi-asserted-by":"crossref","unstructured":"Scully C (2012) Oral and maxillofacial medicine: the basis of diagnosis and treatment. Elsevier Health Sciences.","DOI":"10.1016\/B978-0-7020-4948-4.00002-7"},{"issue":"948","key":"11078_CR82","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1136\/pgmj.2003.017764","volume":"80","author":"SM Selkirk","year":"2004","unstructured":"Selkirk SM (2004) Gene therapy in clinical medicine. Postgrad Med J 80(948):560\u2013570","journal-title":"Postgrad Med J"},{"issue":"11","key":"11078_CR83","doi-asserted-by":"publisher","first-page":"144","DOI":"10.14715\/cmb\/2024.70.11.21","volume":"70","author":"S Shahed Shoarishoar","year":"2024","unstructured":"Shahed Shoarishoar S, KaboodMehri R, Fakor F, Sorouri ZR, Mansour-Ghanaei M, Darkhaneh RF et al (2024) Assessment of decreased ovarian reserve and systemic inflammatory markers. Cell Mol Biol 70(11):144\u2013149","journal-title":"Cell Mol Biol"},{"key":"11078_CR84","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.oraloncology.2017.02.016","volume":"68","author":"MH Shaikh","year":"2017","unstructured":"Shaikh MH, Clarke DT, Johnson NW, McMillan NA (2017) Can gene editing and silencing technologies play a role in the treatment of head and neck cancer? Oral Oncol 68:9\u201319","journal-title":"Oral Oncol"},{"issue":"5","key":"11078_CR85","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1038\/sj.cgt.7700926","volume":"13","author":"E Shillitoe","year":"2006","unstructured":"Shillitoe E (2006) Papillomaviruses as targets for cancer gene therapy. Cancer Gene Ther 13(5):445\u2013450","journal-title":"Cancer Gene Ther"},{"issue":"11","key":"11078_CR86","doi-asserted-by":"publisher","first-page":"109","DOI":"10.14715\/cmb\/2024.70.11.16","volume":"70","author":"SS Shoarishoar","year":"2024","unstructured":"Shoarishoar SS, Milani F, Adineh S, Sorouri ZR, Attari SM (2024) Comparison of pregnancy outcomes in amniocentesis recipients with normal and abnormal maternal serum analytes. Cell Mol Biol (Noisy-Le-Grand) 70(11):109\u2013114","journal-title":"Cell Mol Biol (Noisy-Le-Grand)"},{"issue":"1","key":"11078_CR87","first-page":"203","volume":"3","author":"A Singh","year":"2012","unstructured":"Singh A, Badni M, Singh A, Samadi FM, Kabiraj A (2012) Gene therapy for oral cancer-journey to a new horizon. Oral Maxillofac Pathol J 3(1):203","journal-title":"Oral Maxillofac Pathol J"},{"issue":"1","key":"11078_CR88","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1146\/annurev.mi.49.100195.004111","volume":"49","author":"AE Smith","year":"1995","unstructured":"Smith AE (1995) Viral vectors in gene therapy. Annu Rev Microbiol 49(1):807\u2013838","journal-title":"Annu Rev Microbiol"},{"issue":"2","key":"11078_CR89","first-page":"249","volume":"3","author":"SR Soofiyani","year":"2013","unstructured":"Soofiyani SR, Baradaran B, Lotfipour F, Kazemi T, Mohammadnejad L (2013) Gene therapy, early promises, subsequent problems, and recent breakthroughs. Adv Pharm Bull 3(2):249","journal-title":"Adv Pharm Bull"},{"issue":"6481","key":"11078_CR90","doi-asserted-by":"publisher","first-page":"eaba7365","DOI":"10.1126\/science.aba7365","volume":"367","author":"EA Stadtmauer","year":"2020","unstructured":"Stadtmauer EA, Fraietta JA, Davis MM, Cohen AD, Weber KL, Lancaster E et al (2020) CRISPR-engineered T cells in patients with refractory cancer. Science 367(6481):eaba7365","journal-title":"Science"},{"key":"11078_CR91","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-59745-222-9-3","author":"R Stripecke","year":"2007","unstructured":"Stripecke R, Kasahara N (2007) Lentiviral and retroviral vector systems. Gene Ther Cancer. https:\/\/doi.org\/10.1007\/978-1-59745-222-9-3","journal-title":"Gene Ther Cancer"},{"issue":"6","key":"11078_CR92","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1002\/ijc.11640","volume":"108","author":"T Tamatani","year":"2004","unstructured":"Tamatani T, Azuma M, Ashida Y, Motegi K, Takashima R, Harada K et al (2004) Enhanced radiosensitization and chemosensitization in NF-\u03baB-suppressed human oral cancer cells via the inhibition of \u03b3-irradiation-and 5-FU-induced production of IL-6 and IL-8. Int J Cancer 108(6):912\u2013921","journal-title":"Int J Cancer"},{"key":"11078_CR93","doi-asserted-by":"publisher","DOI":"10.1201\/9780849387999","volume-title":"Gene and cell therapy: therapeutic mechanisms and strategies","author":"NS Templeton","year":"2008","unstructured":"Templeton NS (2008) Gene and cell therapy: therapeutic mechanisms and strategies. Crc Press"},{"issue":"2","key":"11078_CR94","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1053\/ctrv.1998.0107","volume":"25","author":"JMM Terwogt","year":"1999","unstructured":"Terwogt JMM, Schellens JH, ten Bokkel Huinink WW, Beijnen JH (1999) Clinical pharmacology of anticancer agents in relation to formulations and administration routes. Cancer Treat Rev 25(2):83\u2013102","journal-title":"Cancer Treat Rev"},{"key":"11078_CR95","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.biomaterials.2015.11.025","volume":"78","author":"B-K Wang","year":"2016","unstructured":"Wang B-K, Yu X-F, Wang J-H, Li Z-B, Li P-H, Wang H et al (2016) Gold-nanorods-siRNA nanoplex for improved photothermal therapy by gene silencing. Biomaterials 78:27\u201339","journal-title":"Biomaterials"},{"key":"11078_CR96","doi-asserted-by":"publisher","first-page":"187","DOI":"10.2147\/IJN.S150610","volume":"13","author":"D Wang","year":"2018","unstructured":"Wang D, Xu X, Zhang K, Sun B, Wang L, Meng L et al (2018) Codelivery of doxorubicin and MDR1-siRNA by mesoporous silica nanoparticles-polymerpolyethylenimine to improve oral squamous carcinoma treatment. Int J Nanomed 13:187\u2013198","journal-title":"Int J Nanomed"},{"key":"11078_CR97","doi-asserted-by":"publisher","DOI":"10.1016\/j.pdpdt.2021.102218","volume":"34","author":"X Wang","year":"2021","unstructured":"Wang X, Li S, Liu H (2021) Co-delivery of chitosan nanoparticles of 5-aminolevulinic acid and shGBAS for improving photodynamic therapy efficacy in oral squamous cell carcinomas. Photodiagn Photodyn Ther 34:102218","journal-title":"Photodiagn Photodyn Ther"},{"key":"11078_CR98","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1016\/j.jconrel.2022.10.061","volume":"352","author":"H Wang","year":"2022","unstructured":"Wang H, Qin L, Zhang X, Guan J, Mao S (2022) Mechanisms and challenges of nanocarriers as non-viral vectors of therapeutic genes for enhanced pulmonary delivery. J Control Release 352:970\u2013993","journal-title":"J Control Release"},{"issue":"9","key":"11078_CR99","doi-asserted-by":"publisher","first-page":"1812","DOI":"10.1200\/JCO.2000.18.9.1812","volume":"18","author":"JS Waters","year":"2000","unstructured":"Waters JS, Webb A, Cunningham D, Clarke PA, Raynaud F, di Stefano F et al (2000) Phase I clinical and pharmacokinetic study of bcl-2 antisense oligonucleotide therapy in patients with non-Hodgkin\u2019s lymphoma. J Clin Oncol 18(9):1812\u20131823","journal-title":"J Clin Oncol"},{"issue":"2","key":"11078_CR100","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1089\/104303403321070847","volume":"14","author":"D Wodarz","year":"2003","unstructured":"Wodarz D (2003) Gene therapy for killing p53-negative cancer cells: use of replicating versus nonreplicating agents. Hum Gene Ther 14(2):153\u2013159","journal-title":"Hum Gene Ther"},{"issue":"10","key":"11078_CR101","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1089\/104303402320138998","volume":"13","author":"RJ Wong","year":"2002","unstructured":"Wong RJ, Joe JK, Kim S-H, Shah JP, Horsburgh B, Fong Y (2002) Oncolytic herpesvirus effectively treats murine squamous cell carcinoma and spreads by natural lymphatics to treat sites of lymphatic metastases. Hum Gene Ther 13(10):1213\u20131223","journal-title":"Hum Gene Ther"},{"issue":"6","key":"11078_CR102","doi-asserted-by":"publisher","first-page":"2213","DOI":"10.1002\/cam4.2880","volume":"9","author":"J Wu","year":"2020","unstructured":"Wu J, Guo Q, Zhang G, Zhao L, Lv Y, Wang J et al (2020) Study on the targeted therapy of oral squamous cell carcinoma with a plasmid expressing PE38KDEL toxin under control of the SERPINB3 promoter. Cancer Med 9(6):2213\u20132222","journal-title":"Cancer Med"},{"issue":"1","key":"11078_CR103","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1177\/154405910308200104","volume":"82","author":"S Xi","year":"2003","unstructured":"Xi S, Grandis J (2003) Gene therapy for the treatment of oral squamous cell carcinoma. J Dent Res 82(1):11\u201316","journal-title":"J Dent Res"},{"key":"11078_CR104","doi-asserted-by":"publisher","first-page":"2401","DOI":"10.1016\/j.csbj.2020.08.031","volume":"18","author":"Y Xu","year":"2020","unstructured":"Xu Y, Li Z (2020) CRISPR-Cas systems: overview, innovations and applications in human disease research and gene therapy. Comput Struct Biotechnol J 18:2401\u20132415","journal-title":"Comput Struct Biotechnol J"},{"key":"11078_CR105","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/BF02977789","volume":"28","author":"C Xu","year":"2005","unstructured":"Xu C, Li CY-T, Kong A-NT (2005) Induction of phase I, II and III drug metabolism\/transport by xenobiotics. Arch Pharm Res 28:249\u2013268","journal-title":"Arch Pharm Res"},{"issue":"12","key":"11078_CR106","first-page":"967","volume":"33","author":"M Young","year":"2005","unstructured":"Young M, Overlid N, Konopka K, D\u00fczg\u00fcnes N (2005) Gene therapy of oral cancer: efficient delivery of a \u2018suicide gene\u2019to murine oral cancer cells in physiological milieu. J Calif Dent Assoc 33(12):967\u2013971","journal-title":"J Calif Dent Assoc"},{"key":"11078_CR107","doi-asserted-by":"publisher","first-page":"813","DOI":"10.2217\/17435889.3.6.813","volume":"3","author":"D Yu","year":"2008","unstructured":"Yu D, Wang A, Huang H, Chen Y (2008) PEG-PBLG nanoparticle-mediated HSV-TK\/GCV gene therapy for oral squamous cell carcinoma. Nanomedicine 3:813","journal-title":"Nanomedicine"},{"key":"11078_CR108","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1007\/s00277-012-1430-5","volume":"91","author":"C Zuccato","year":"2012","unstructured":"Zuccato C, Breda L, Salvatori F, Breveglieri G, Gardenghi S, Bianchi N et al (2012) A combined approach for \u03b2-thalassemia based on gene therapy-mediated adult hemoglobin (HbA) production and fetal hemoglobin (HbF) induction. Ann Hematol 91:1201\u20131213","journal-title":"Ann Hematol"}],"container-title":["Biochemical Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10528-025-11078-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10528-025-11078-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10528-025-11078-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T11:02:42Z","timestamp":1773399762000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10528-025-11078-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,11]]},"references-count":108,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["11078"],"URL":"https:\/\/doi.org\/10.1007\/s10528-025-11078-3","relation":{},"ISSN":["0006-2928","1573-4927"],"issn-type":[{"value":"0006-2928","type":"print"},{"value":"1573-4927","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,11]]},"assertion":[{"value":"13 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All authors agree to submit the manuscript for publications.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}}]}}